UCI – Das Tumorzentrum Bern - Navigation
{"headers":{"title":"Title","year":"Year","type":"Type"},"rows":[{"title":"Koster, K.-L., Colombo, I., Eckhardt, K., Hayoz, S., Rojas Mora, A., Hess, D., Haefliger, S., Imbimbo, M., Britschgi, C., Bertoni, F., Homicsko, K., Joerger, M., Stathis, A., von Moos, R., \u0026 Sessa, C. (2025). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/222447\u0022\u003EA retrospective analysis of phase I and phase I\/II investigator-initiated clinical trials conducted by the Swiss Group for Clinical Cancer Research (SAKK)\u003C\/a\u003E. \u003Ci\u003EESMO Open\u003C\/i\u003E, \u003Ci\u003E10\u003C\/i\u003E(11), 105876.","year":2025,"type":"Journal Article (Original Article)"},{"title":"Paulson, K. G., Lau, S. C. M., Ahn, M.-J., Moskovitz, M., Pogorzelski, M., H\u00e4fliger, S., Parkes, A., Zhang, Y., Hamidi, A., Thompson, C. G., \u0026 Wermke, M. (2025). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/218933\u0022\u003ESafety and activity of tarlatamab in combination with a PD-L1 inhibitor as first-line maintenance therapy after chemo-immunotherapy in patients with extensive-stage small-cell lung cancer (DeLLphi-303): a multicentre, non-randomised, phase 1b study\u003C\/a\u003E. \u003Ci\u003EThe Lancet Oncology\u003C\/i\u003E, \u003Ci\u003E26\u003C\/i\u003E, 1300-1311.","year":2025,"type":"Journal Article (Original Article)"},{"title":"Lopez, J. S., Haefliger, S., Plummer, R., Clement, P. M., Jeffry Evans, T. R., L\u00e4ubli, H., Roth, P., Kristeleit, R., Brazil, L., Tabatabai, G., Wick, A., Wunderlich, B., Beebe, K., Eisner, J. R., Lane, H., Engelhardt, M., Kaindl, T., Hau, P., Hundsberger, T., \u0026 Steinbach, J. (2025). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/212281\u0022\u003EA phase 1\/2a dose-finding study and biomarker assessment of oral lisavanbulin in patients with high-grade glioma or glioblastoma\u003C\/a\u003E. \u003Ci\u003ECell Reports Medicine\u003C\/i\u003E, \u003Ci\u003E6\u003C\/i\u003E(6), 102165.","year":2025,"type":"Journal Article (Original Article)"},{"title":"Skoulidis, F., Li, B. T., Hochmair, M., Govindan, R., Vincent, M., van der Wekken, A. J., Reguart Aransay, N., O\u2019Byrne, K. J., Girard, N., Griesinger, F., Nishio, M., H\u00e4fliger, S., Lindsay, C., Reinmuth, N., Paulus, A., Papakotoulas, P., Kim, S.-W., Ferreira, C. G., Pasello, G., \u2026 de Langen, A. J. (2025). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/203463\u0022\u003EPooled safety analysis and management of sotorasib-related adverse events in KRAS G12C-mutated advanced non-small cell lung cancer\u003C\/a\u003E. \u003Ci\u003EThe Oncologist\u003C\/i\u003E, \u003Ci\u003E30\u003C\/i\u003E(1).","year":2025,"type":"Journal Article (Original Article)"},{"title":"Huwyler, F., Giger, R., Bill, R., Rauch, D., \u0026 H\u00e4fliger, S. (2024). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/194347\u0022\u003EResponse to induction chemotherapy as a prognostic indicator in locally advanced head and neck squamous cell carcinoma\u003C\/a\u003E. \u003Ci\u003EJournal of Cancer Research and Clinical Oncology\u003C\/i\u003E, \u003Ci\u003E151\u003C\/i\u003E(1), 2.","year":2024,"type":"Journal Article (Original Article)"},{"title":"Pradervand, S., Freundler, N., Gosztonyi, B., Roncoroni, L., Achermann, R., Schwenk, T., de Fraipont, G., Garessus, J., Haefliger, S., Leichtle, A. B., Kiessling, M., Mueller-Focke, T., Krebs, F., Zoete, V., Tsantoulis, P., Michielin, O., Britschgi, C., \u0026 Wicki, A. (2024). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/195475\u0022\u003EReal-world occurrence, therapy, and outcome of patients with class 2 or 3 BRAF compared with class 1 BRAF-mutated cancers\u003C\/a\u003E. \u003Ci\u003EESMO Real World Data and Digital Oncology\u003C\/i\u003E, \u003Ci\u003E6\u003C\/i\u003E.","year":2024,"type":"Journal Article (Original Article)"},{"title":"Abdipourbozorgbaghi, M., Vancura, A., Radpour, R., \u0026 Haefliger, S. (2024). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/44703\u0022\u003ECirculating miRNA panels as a novel non-invasive diagnostic, prognostic, and potential predictive biomarkers in non-small cell lung cancer (NSCLC)\u003C\/a\u003E. \u003Ci\u003EBritish Journal of Cancer\u003C\/i\u003E, \u003Ci\u003E131\u003C\/i\u003E(8), 1350-1362.","year":2024,"type":"Journal Article (Original Article)"},{"title":"Schmid, K. F., Zeinali, S., Moser, S. K., Christelle Dubey, Schneider, S., Deng, H., H\u00e4fliger, S., Marti, T. M., \u0026 Guenat, O. T. (2024). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/124271\u0022\u003EAssessing the metastatic potential of circulating tumor cells using an organ-on-chip model\u003C\/a\u003E. \u003Ci\u003EFrontiers in Bioengineering and Biotechnology\u003C\/i\u003E, \u003Ci\u003E12\u003C\/i\u003E.","year":2024,"type":"Journal Article (Original Article)"},{"title":"Mc Laughlin, A. M., Hess, D., Michelet, R., Colombo, I., H\u00e4fliger, S., Bastian, S., Rabaglio, M. E., Schwitter, M., Fischer, S., Eckhardt, K., Hayoz, S., Kopp, C., Klose, M., Sessa, C., Stathis, A., Halbherr, S., Huisinga, W., Joerger, M., \u0026 Kloft, C. (2024). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/178195\u0022\u003EPopulation pharmacokinetics of TLD-1, a novel liposomal doxorubicin, in a phase I trial\u003C\/a\u003E. \u003Ci\u003ECancer Chemotherapy and Pharmacology\u003C\/i\u003E, \u003Ci\u003E94\u003C\/i\u003E(3), 349-360.","year":2024,"type":"Journal Article (Original Article)"},{"title":"Schoenfeld, A. J., Lee, S. M., Doger de Speville, B., Gettinger, S. N., H\u00e4fliger, S., Sukari, A., Papa, S., Rodriguez-Moreno, J. F., Graf Finckenstein, F., Fiaz, R., Catlett, M., Chen, G., Qi, R., Masteller, E. L., Gontcharova, V., \u0026 He, K. (2024). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/176441\u0022\u003ELifileucel, an Autologous Tumor-infiltrating Lymphocyte Monotherapy, in Patients with Advanced Non-small Cell Lung Cancer Resistant to Immune Checkpoint Inhibitors\u003C\/a\u003E. \u003Ci\u003ECancer Discovery\u003C\/i\u003E, \u003Ci\u003E14\u003C\/i\u003E(8), 1389-1402.","year":2024,"type":"Journal Article (Original Article)"},{"title":"Coan, M., H\u00e4fliger, S., Ounzain, S., \u0026 Johnson, R. B. (2024). [Review of \u003Ci\u003E\u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/175055\u0022\u003ETargeting and engineering long non-coding RNAs for cancer therapy.\u003C\/a\u003E\u003C\/i\u003E]. \u003Ci\u003ENature Reviews. Genetics\u003C\/i\u003E, \u003Ci\u003E25\u003C\/i\u003E(8), 578-595.","year":2024,"type":"Journal Article (Review)"},{"title":"Bocchi, F., H\u00e4fliger, S., Schmid, S., \u0026 Sidler, D. (2024). [Review of \u003Ci\u003E\u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/178015\u0022\u003EImmune checkpoint inhibitors and renal toxicity.\u003C\/a\u003E\u003C\/i\u003E]. \u003Ci\u003EHeliyon\u003C\/i\u003E, \u003Ci\u003E10\u003C\/i\u003E(11).","year":2024,"type":"Journal Article (Review)"},{"title":"Eli\u00e7in, O., H\u00e4fliger, S., \u0026 Dorn, P. (2024). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/178863\u0022\u003ESAKK 16\/18: QA and interim safety of immune-modulatory RT in resectable stage III(N2) NSCLC\u003C\/a\u003E. In \u003Ci\u003ERadiotherapy and oncology\u003C\/i\u003E (Vols. 194, Issue 1, p. S1610). ESTRO 2024, Glasgow,UK. Elsevier.","year":2024,"type":"Conference Paper"},{"title":"Colombo, I., Koster, K.-L., Holer, L., H\u00e4fliger, S., Rabaglio, M. E., Bastian, S., Schwitter, M., Eckhardt, K., Hayoz, S., Mc Laughlin, A. M., Kloft, C., Klose, M., Halbherr, S., Baumgartner, C., Sessa, C., Stathis, A., Hess, D., \u0026 Joerger, M. (2024). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/174627\u0022\u003ETLD-1, a novel liposomal doxorubicin, in patients with advanced solid tumors: Dose escalation and expansion part of a multicenter open-label phase I trial (SAKK 65\/16)\u003C\/a\u003E. \u003Ci\u003EEuropean Journal of Cancer\u003C\/i\u003E, \u003Ci\u003E201\u003C\/i\u003E(113588), 113588.","year":2024,"type":"Journal Article (Original Article)"},{"title":"Wahli, M. N., Hayoz, S., Hoch, D., Ryser, C. O., Hoffmann, M., Scherz, A., Schwacha-Eipper, B., H\u00e4fliger, S., Wampfler, J., Berger, M. D., Novak, U., \u0026 \u00d6zdemir, B. (2023). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/86982\u0022\u003EThe role of immune checkpoint inhibitors in clinical practice: an analysis of the treatment patterns, survival and toxicity rates by sex\u003C\/a\u003E. \u003Ci\u003EJournal of Cancer Research and Clinical Oncology\u003C\/i\u003E, \u003Ci\u003E149\u003C\/i\u003E(7), 3847-3858.","year":2023,"type":"Journal Article (Original Article)"},{"title":"Joerger, M., Hundsberger, T., H\u00e4fliger, S., von Moos, R., Hottinger, A. F., Kaindl, T., Engelhardt, M., Marszewska, M., Lane, H., Roth, P., \u0026 Stathis, A. (2023). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/121669\u0022\u003ESafety and anti-tumor activity of lisavanbulin administered as 48-hour infusion in patients with ovarian cancer or recurrent glioblastoma: a phase 2a study\u003C\/a\u003E. \u003Ci\u003EInvestigational New Drugs\u003C\/i\u003E, \u003Ci\u003E41\u003C\/i\u003E(2), 267-275.","year":2023,"type":"Journal Article (Original Article)"},{"title":"Bar, J., Peled, N., Schokrpur, S., Wolner, M., Rotem, O., Girard, N., Nana, F. A., Derijcke, S., Kian, W., Patel, S., Gantz-Sorotsky, H., Zer, A., Moskovitz, M., Metro, G., Rottenberg, Y., Calles, A., Hochmair, M., Cuppens, K., Decoster, L., \u2026 Addeo, A. (2023). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/88451\u0022\u003EUNcommon EGFR mutations: International Case series on efficacy of osimertinib in Real-life practice in first liNe setting (UNICORN)\u003C\/a\u003E. \u003Ci\u003EJournal of Thoracic Oncology\u003C\/i\u003E, \u003Ci\u003E18\u003C\/i\u003E(2), 169-180.","year":2023,"type":"Journal Article (Original Article)"},{"title":"Frehner, L. H., H\u00e4fliger, S., Cerciello, F., Grob, T., \u0026 Schmid, S. (2023). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/170993\u0022\u003EComplete Response on Larotrectinib in NTRK2 Fusion-Positive Non-Small Cell Lung Cancer\u003C\/a\u003E. \u003Ci\u003ECase Reports in Oncology\u003C\/i\u003E, \u003Ci\u003E16\u003C\/i\u003E(1), 871-877.","year":2023,"type":"Journal Article (Further Contribution)"},{"title":"Vancura, A. N., Gutierrez, A. H., Hennig, T., Pulido Quetglas, C., Slack, F. J., Johnson, R. B., \u0026 H\u00e4fliger, S. (2022). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/116543\u0022\u003EIs Evolutionary Conservation a Useful Predictor for Cancer Long Noncoding RNAs? Insights from the Cancer LncRNA Census 3\u003C\/a\u003E. \u003Ci\u003ENon-Coding RNA\u003C\/i\u003E, \u003Ci\u003E8\u003C\/i\u003E(6).","year":2022,"type":"Journal Article (Original Article)"},{"title":"Addeo, A., Rothschild, S. I., Holer, L., Schneider, M., Waibel, C., H\u00e4fliger, S., Mark, M., Fernandez, E., Mach, N., Mauti, L., Jermann, P. M., Alborelli, I., Calgua, B., Savic-Prince, S., Joerger, M., \u0026 Fr\u00fch, M. (2022). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/87396\u0022\u003EFibroblast growth factor receptor (FGFR) inhibitor rogaratinib in patients with advanced pretreated squamous-cell non-small cell lung cancer over-expressing FGFR mRNA: The SAKK 19\/18 phase II study\u003C\/a\u003E. \u003Ci\u003ELung Cancer\u003C\/i\u003E, \u003Ci\u003E172\u003C\/i\u003E, 154-159.","year":2022,"type":"Journal Article (Original Article)"},{"title":"Esposito, R., Polidori, T., Meise, D. F., Pulido Quetglas, C., Chouvardas, P., Forster, S., Schaerer, P., Kobel, A., Schlatter, J., Kerkhof, E., R\u00f6mmele, M., Rice, E. S., Zhu, L., Lanz\u00f3s, A., Guillen Ramirez, H. A., Basile, G., Carrozzo, I., Vancura, A. N., Ullrich, S., \u2026 Johnson, R. B. (2022). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/87919\u0022\u003EMulti-hallmark long noncoding RNA maps reveal non-small cell lung cancer vulnerabilities\u003C\/a\u003E. \u003Ci\u003ECell Genomics\u003C\/i\u003E, \u003Ci\u003E2\u003C\/i\u003E(9), 100171.","year":2022,"type":"Journal Article (Original Article)"},{"title":"Krebs, F. S., Britschgi, C., Pradervand, S., Achermann, R., Tsantoulis, P., H\u00e4fliger, S., Wicki, A., Michielin, O., \u0026 Zoete, V. (2022). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/86350\u0022\u003EStructure-based prediction of BRAF mutation classes using machine-learning approaches\u003C\/a\u003E. \u003Ci\u003EScientific Reports\u003C\/i\u003E, \u003Ci\u003E12\u003C\/i\u003E(1), 12528.","year":2022,"type":"Journal Article (Original Article)"},{"title":"Vancura, A. N., Lanzos Camaioni, A. A., Bosch-Guiteras, N., Esteban, M. T., Gutierrez, A. H., H\u00e4fliger, S., \u0026 Johnson, R. B. (2021). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/57242\u0022\u003ECancer LncRNA Census 2 (CLC2): an enhanced resource reveals clinical features of cancer lncRNAs\u003C\/a\u003E. \u003Ci\u003ENAR Cancer\u003C\/i\u003E, \u003Ci\u003E3\u003C\/i\u003E(2), zcab013.","year":2021,"type":"Journal Article (Original Article)"},{"title":"H\u00e4fliger, S., Seidel, A.-K., Schoch, E., Reichmann, J., Wild, D., Steinmann-Schwager, S., \u0026 Pless, M. (2020). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/43537\u0022\u003EPeptide Receptor Radionuclide Therapy for a Phosphaturic Mesenchymal Tumor\u003C\/a\u003E. \u003Ci\u003ECase Reports in Oncology\u003C\/i\u003E, \u003Ci\u003E13\u003C\/i\u003E(3), 1373-1380.","year":2020,"type":"Journal Article (Further Contribution)"},{"title":"Tiede, S., Meyer-Schaller, N., Kalathur, R. K. R., Ivanek, R., Fagiani, E., Schmassmann, P., Stillhard, P., H\u00e4fliger, S., Kraut, N., Schweifer, N., Waizenegger, I. C., Bill, R., \u0026 Christofori, G. (2018). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/62923\u0022\u003EThe FAK inhibitor BI 853520 exerts anti-tumor effects in breast cancer\u003C\/a\u003E. \u003Ci\u003EOncogenesis\u003C\/i\u003E, \u003Ci\u003E7\u003C\/i\u003E(9), 73.","year":2018,"type":"Journal Article (Original Article)"}]}
